BIOGEN INC. Inventory, Noncurrent
BIOGEN INC. (BIIB) had Inventory, Noncurrent of $139.50 million as of 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:InventoryNoncurrent · last filed 2026-04-29
- 2026-03-31: Inventory, Noncurrent $139.50M.
- 2025-12-31: Inventory, Noncurrent $145.40M.
- 2025-09-30: Inventory, Noncurrent $162.30M.
- 2025-06-30: Inventory, Noncurrent $150.60M.
| Period end | Inventory, Noncurrent |
|---|---|
| 2026-03-31 | $139.50M 10-Q · filed 2026-04-29 |
| 2025-12-31 | $145.40M 10-Q · filed 2026-04-29 |
| 2025-09-30 | $162.30M 10-Q · filed 2025-10-30 |
| 2025-06-30 | $150.60M 10-Q · filed 2025-07-31 |
| 2025-03-31 | $117.40M 10-Q · filed 2025-05-01 |
| 2024-12-31 | $93.90M 10-K · filed 2026-02-06 |
| 2024-09-30 | $94.50M 10-Q · filed 2024-10-30 |
| 2024-06-30 | $111.30M 10-Q · filed 2024-08-01 |
| 2024-03-31 | $94.90M 10-Q · filed 2024-04-24 |
| 2023-12-31 | $81.70M 10-K · filed 2025-02-12 |
| 2023-09-30 | $55.90M 10-Q · filed 2023-11-08 |
| 2023-06-30 | $65.80M 10-Q · filed 2023-07-25 |
| 2023-03-31 | $42.20M 10-Q · filed 2023-04-25 |
| 2022-12-31 | $21.10M 10-K · filed 2024-02-14 |
| 2021-12-31 | $0.00 10-K · filed 2023-02-15 |
| 2019-12-31 | $0.00 10-K · filed 2020-02-06 |
| 2019-09-30 | $0.00 10-Q · filed 2019-10-22 |
| 2019-06-30 | $0.00 10-Q · filed 2019-07-24 |
| 2019-03-31 | $0.00 10-Q · filed 2019-04-24 |
| 2018-12-31 | $6.60M 10-K · filed 2020-02-06 |
| 2018-09-30 | $9.70M 10-Q · filed 2018-10-23 |
| 2018-06-30 | $12.90M 10-Q · filed 2018-07-24 |
| 2018-03-31 | $15.80M 10-Q · filed 2018-04-24 |
| 2017-12-31 | $22.80M 10-K · filed 2019-02-06 |
| 2017-09-30 | $24.00M 10-Q · filed 2017-10-24 |
| 2017-06-30 | $25.30M 10-Q · filed 2017-07-25 |
| 2017-03-31 | $37.80M 10-Q · filed 2017-04-25 |
| 2016-12-31 | $37.80M 10-K · filed 2018-02-01 |
| 2016-09-30 | $39.80M 10-Q · filed 2016-10-26 |
| 2016-06-30 | $32.30M 10-Q · filed 2016-07-21 |
| 2016-03-31 | $36.90M 10-Q · filed 2016-04-21 |
| 2015-12-31 | $40.20M 10-K · filed 2017-02-02 |
| 2014-12-31 | $0.00 10-K · filed 2016-02-03 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |